Early Screening and Treatment of Women With Prediabetes in Pregnancy

Not Recruiting

Trial ID: NCT01552213


The investigators hope to learn whether treatment with medical nutrition therapy (MNT) for pregnant women with prediabetes decreases the rate and severity of impaired glucose tolerance later in pregnancy and improves perinatal outcomes. Given the rising rates of obesity and diabetes in this country even among young women and the adverse affects of diabetes of pregnant women and their infants, the investigators feel that it is important to not only identify women at high risk for diabetes early in pregnancy but determine the appropriate management strategy

Official Title

A Randomized Controlled Trial of Early Screening and Treatment of Women With Prediabetes in Pregnancy

Stanford Investigator(s)

Yasser El-Sayed, Professor
Yasser El-Sayed, Professor

Charles B. and Ann L. Johnson Professor in the School of Medicine and Professor, by courtesy, of Pediatrics (Neonatology) and of Surgery


Inclusion Criteria:

   - Age 18 or older

   - Singleton pregnancy

   - Prenatal care established at less than 14 weeks

   - A1C 5.7-6.4%

   - Delivery planned at Lucille Packard Children's Hospital at Stanford University (LPCH)
   or Santa Clara Valley Medical Center (SVMC)

Exclusion Criteria:

   - preexisting diabetes or chronic steroid use

   - known major fetal anomalies


other: Minimum intervention control group

other: Treatment for glucose intolerance

Not Recruiting

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Sarah S Osmundson, MD